APUS
Income statement / Annual
Last year (2025), Apimeds Pharmaceuticals US Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Apimeds Pharmaceuticals US Inc.'s net income was -$6.00 M.
See Apimeds Pharmaceuticals US Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$5.71 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$5.71 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$1.63 B
|
$0.00
|
$98.54 K
|
$368.00 K
|
$489.94 K
|
| General & Administrative Expenses |
$10.28 B
|
$1.28 M
|
$648.89 K
|
$271.53 K
|
$529.56 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$10.28 B
|
$1.28 M
|
$648.89 K
|
$271.53 K
|
$529.56 K
|
| Other Expenses |
-$11.90 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$11.91 M
|
$1.28 M
|
$747.44 K
|
$639.53 K
|
$1.02 M
|
| Cost And Expenses |
$11.91 M
|
$1.28 M
|
$747.44 K
|
$639.53 K
|
$1.02 M
|
| Interest Income |
$107.60 K
|
$2.82 K
|
$7.81 K
|
$0.00
|
$0.00
|
| Interest Expense |
$283.01 K
|
$117.72 K
|
$38.07 K
|
$29.14 K
|
$6.74 K
|
| Depreciation & Amortization |
$5.71 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| EBITDA |
-$11.91 M |
-$1.27 M |
-$739.63 K |
-$639.53 K |
-$1.02 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$5.91 M
|
-$114.90 K
|
-$30.26 K
|
-$29.14 K
|
-$6.74 K
|
| Income Before Tax |
-$6.00 M
|
-$1.39 M
|
-$777.69 K
|
-$668.67 K
|
-$1.03 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$6.00 M
|
-$1.39 M
|
-$777.69 K
|
-$668.67 K
|
-$1.03 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.55 |
-1.2 |
-0.675 |
-0.58 |
-0.89 |
| EPS Diluted |
-0.55 |
-1.1 |
-0.613 |
-0.527 |
-0.808 |
| Weighted Average Shares Out |
$10.88 M
|
$1.15 M
|
$1.15 M
|
$1.15 M
|
$1.15 M
|
| Weighted Average Shares Out Diluted |
$10.88 M
|
$1.27 M
|
$1.27 M
|
$1.27 M
|
$1.27 M
|
| Link |
|
|
|
|
|
